CYBB and endothelial dysfunction: Another metabolite, butyrate, can pass through the PPARδ/Mir-181b pathway to reduce NOX2 expression and ROS production in vascular endothelial cells, thereby preventing endothelial dysfunction in atherosclerosis [32].